Sunshine Biopharma Inc. Effective Tax Rate
Sunshine Biopharma Inc. (SBFM) reported Effective Tax Rate of -0.36% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-04-03
- Sunshine Biopharma Inc. effective income tax rate reconciliation, percent for the quarter ending 2024-03-31 was 26.83%, a 0.00% change year-over-year.
- Sunshine Biopharma Inc. effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was 26.83%.
- Sunshine Biopharma Inc. effective income tax rate reconciliation, percent for fiscal 2025 was -0.36%, a 108.24% decline from fiscal 2024.
- Sunshine Biopharma Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 4.37%.
- Sunshine Biopharma Inc. effective income tax rate reconciliation, percent for fiscal 2023 was -9.62%.
- Sunshine Biopharma Inc. effective income tax rate reconciliation, percent for fiscal 2018 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -0.36% 10-K · filed 2026-04-03 | |||
| 2024-12-31 | 4.37% 10-K · filed 2026-04-03 | 4.40% 10-K · filed 2025-04-01 | ||
| 2024-03-31 | 26.83% 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | -9.62% 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 26.83% 10-Q · filed 2023-11-13 | |||
| 2023-03-31 | 26.83% 10-Q · filed 2024-05-20 | |||
| 2022-09-30 | 26.83% 10-Q · filed 2023-11-13 | |||
| 2018-12-31 | 0.00% 10-K · filed 2019-04-12 | |||
| 2017-12-31 | 0.00% 10-K · filed 2019-04-12 | |||
| 2016-12-31 | 0.00% 10-K · filed 2018-04-02 | |||
| 2015-12-31 | 0.00% 10-K · filed 2017-04-17 | |||
| 2014-12-31 | 0.00% 10-K · filed 2016-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |